PerkinElmer Kicks off 2014 Asia-Pacific City Tour
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the kick-off of its 2014 Asia-Pacific City Tour themed "From In Vitro to In Vivo to Human, Discover the Mysteries of Life." This series of events expands upon PerkinElmer's 2013 China City Tour to include South Korea, Australia and Japan.
PerkinElmer's City Tour provides a platform for sharing knowledge and practices in life sciences research to effectively help researchers develop and optimize their innovative applications, products and processes.
Experts from different fields will present the latest findings in biological, pharmaceutical and disease research, along with opinions about future trends and technology solutions available in the marketplace. In addition, PerkinElmer will showcase and provide demos of its innovative technologies, comprehensive experimental solutions and service offerings.
|WHERE:||PerkinElmer's tour begins in Beijing, China on May 7, and will continue on to Australia, Japan and South Korea. Specific schedules and presentation themes will vary in each of the different cities. For more information on the 2014 Asia-Pacific City Tour and PerkinElmer's life sciences research and application solutions, please visit http://go.perkinelmer.com/2014citytour|
"We are very pleased to be hosting an Asia-Pacific wide event this year to help advance the understanding of biology, which aids in the development of disease treatment options," said Dr. Martina Bielefeld Sévigny, Vice President and General Manager, Sales, APAC, PerkinElmer. "Together with experts from different fields, PerkinElmer will share our insights and information to help scientists and researchers address their challenges and support in their research efforts."
PerkinElmer provides life sciences solutions and technology spanning molecular, cellular and clinical research. The Company offers a wide range of cutting-edge technologies, including multi-label detection, multi-dimensional live cell imaging, animal imaging, and data management and analysis platforms.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2013, has about 7,600 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.